DAXOR CORPORATION - CLOSED END FUND
8.6075
04-October-24 12:52:20
15 minutes delayed
Stocks
-0.3525
-3.93%
Today's range
8.6075 - 9.0050
ISIN
N/A
Source
NASDAQ
-
18 Mar 2024 14:18:00 By Nasdaq GlobeNewswire
-
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
11 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
08 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
26 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions
12 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
07 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
29 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress
16 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 08:30:00 By Nasdaq GlobeNewswire
-
13 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
Daxor Corporation Awarded New Patent for Remote Monitoring of Blood Volume
09 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
13 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2023
27 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 08:00:01 By Nasdaq GlobeNewswire
-
11 Sep 2023 12:00:00 By Nasdaq GlobeNewswire
-
Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07 Sep 2023 09:15:00 By Nasdaq GlobeNewswire
-
28 Aug 2023 16:15:00 By Nasdaq GlobeNewswire